Literature DB >> 12941608

NUFIP1 (nuclear FMRP interacting protein 1) is a nucleocytoplasmic shuttling protein associated with active synaptoneurosomes.

Barbara Bardoni1, Rob Willemsen, Ivan Jeanne Weiler, Annette Schenck, Lies-Anne Severijnen, Colette Hindelang, Enzo Lalli, Jean-Louis Mandel.   

Abstract

Fragile X syndrome, the most common cause of inherited mental retardation, is caused by the absence of FMRP (Fragile X Mental Retardation Protein). FMRP is an RNA binding protein reported to be involved in translational control, notably at postsynaptic sites of protein synthesis as a part of a multiprotein/mRNA complex. One of the FMRP interactors, NUFIP1, is an RNA binding protein with an expression profile matching that of FMRP. We now show that in the nucleus NUFIP1 is localized in the nuclear matrix in RNA-containing structures lying in the proximity of, but not overlapping with, sites of nascent RNA. NUFIP1 is also present in the cytoplasm, where it is associated with ribosomes, similarly to FMRP. In neurons NUFIP1 can be detected in functional synaptoneurosomes, colocalizing with ribosomes. Consistent with its subcellular localization in both nucleus and cytoplasm, we show that NUFIP1 contains a functional CRM1-dependent nuclear export signal and is able to shuttle between these two cellular compartments. These findings suggest the involvement of NUFIP1 in the export and localization of mRNA and, in association with FMRP, in the regulation of local protein synthesis near synapses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941608     DOI: 10.1016/s0014-4827(03)00222-2

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  20 in total

1.  NUFIP1 is a ribosome receptor for starvation-induced ribophagy.

Authors:  Gregory A Wyant; Monther Abu-Remaileh; Evgeni M Frenkel; Nouf N Laqtom; Vimisha Dharamdasani; Caroline A Lewis; Sze Ham Chan; Ivonne Heinze; Alessandro Ori; David M Sabatini
Journal:  Science       Date:  2018-04-26       Impact factor: 47.728

2.  Ribophagy: new receptor discovered.

Authors:  Donna Denton; Sharad Kumar
Journal:  Cell Res       Date:  2018-07       Impact factor: 25.617

3.  Finding a ribophagy receptor.

Authors:  Meiyan Jin; Daniel J Klionsky
Journal:  Autophagy       Date:  2018-08-01       Impact factor: 16.016

Review 4.  Nervous translation, do you get the message? A review of mRNPs, mRNA-protein interactions and translational control within cells of the nervous system.

Authors:  Ross Smith; Reena Jagdish Rathod; Shalini Rajkumar; Derek Kennedy
Journal:  Cell Mol Life Sci       Date:  2014-06-22       Impact factor: 9.261

Review 5.  Ribosome Abundance Control Via the Ubiquitin-Proteasome System and Autophagy.

Authors:  Heeseon An; J Wade Harper
Journal:  J Mol Biol       Date:  2019-06-11       Impact factor: 5.469

6.  Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles.

Authors:  Edouard W Khandjian; Marc-Etienne Huot; Sandra Tremblay; Laetitia Davidovic; Rachid Mazroui; Barbara Bardoni
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

7.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

8.  Zfrp8 forms a complex with fragile-X mental retardation protein and regulates its localization and function.

Authors:  William Tan; Curtis Schauder; Tatyana Naryshkina; Svetlana Minakhina; Ruth Steward
Journal:  Dev Biol       Date:  2016-01-07       Impact factor: 3.582

9.  The fragile X mental retardation protein has nucleic acid chaperone properties.

Authors:  Caroline Gabus; Rachid Mazroui; Sandra Tremblay; Edouard W Khandjian; Jean-Luc Darlix
Journal:  Nucleic Acids Res       Date:  2004-04-19       Impact factor: 16.971

10.  Retinoblastoma and mental retardation microdeletion syndrome: clinical characterization and molecular dissection using array CGH.

Authors:  R Caselli; C Speciale; C Pescucci; V Uliana; K Sampieri; M Bruttini; I Longo; S De Francesco; T Pramparo; O Zuffardi; R Frezzotti; A Acquaviva; T Hadjistilianou; A Renieri; F Mari
Journal:  J Hum Genet       Date:  2007-05-15       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.